Enhancing advanced therapy product quality: how CDMOs are leveraging Oxford Nanopore sequencing скачать в хорошем качестве

Enhancing advanced therapy product quality: how CDMOs are leveraging Oxford Nanopore sequencing

Discover how CDMOs like Ascend Advanced Therapies are redefining rAAV characterisation using Oxford Nanopore sequencing. In this expert-led webinar, we explore how Oxford Nanopore technology enables high-resolution analysis of recombinant adeno-associated virus (rAAV) vectors, offering insights into: Vector genome identity Truncation hotspots Product-related DNA impurities Encapsidated host-cell DNA Whether you’re working in gene therapy development, CDMO analytics, or vector production, this session will show how modern sequencing tools are helping teams accelerate progress from development to clinical evaluation. Watch now to learn how Oxford Nanopore sequencing is helping organisations transform their analytical workflows and achieve richer insight.